Showing results (101-110 of 304) with videos related to

Sort By:
Pageof 31
Human Genomics|November 10, 2023
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicityElena De Mattia, Jerry Polesel, Marco Silvestri, et al.
Cancers|November 14, 2023
A Randomized Clinical Trial Investigating an Integrated Nursing Educational Program to Mitigate Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: The NIV-EC TrialCristina Mazzega-Fabbro, Jerry Polesel, Lara Brusutti, et al.
ACS Omega|November 8, 2021
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2 NS) for Ovarian Cancer TherapyMuhammad Adeel, Salvatore Parisi, Matteo Mauceri, et al.
Anti-Cancer Drugs|August 2, 2007
Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cellsFabio Puglisi, Claudia Andreetta, Francesca Valent, et al.
Melanoma Research|February 1, 2019
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanomaDonatella Iacono, Debora Basile, Lorenzo Gerratana, et al.
International Journal of Molecular Sciences|May 31, 2020
Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-AnalysisMichele Bartoletti, Giacomo Pelizzari, Lorenzo Gerratana, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 22, 2025
Imatinib and norimatinib therapeutic monitoring using dried blood spots: Analytical and clinical validation, and performance comparison of volumetric collection devicesMarco Orleni, Sara Gagno, Eleonora Cecchin, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case ReportCamilla Lisanti, Serena Della Rossa, Emma Zottarelli, et al.
International Journal of Molecular Sciences|January 25, 2025
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic ApproachesLorenzo Foffano, Elisa Bertoli, Martina Bortolot, et al.
Cancer Treatment Reviews|February 28, 2026
Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trialsRiccardo Vida, Michele Bartoletti, Marcella Montico, et al.
Pageof 31